Department of Immunobiology, University of Arizona, Tucson, Arizona, USA.
BIO5 Institute, University of Arizona, Tucson, Arizona, USA.
J Virol. 2023 Jul 27;97(7):e0075823. doi: 10.1128/jvi.00758-23. Epub 2023 Jun 20.
Liver X receptor (LXR) signaling broadly restricts virus replication; however, the mechanisms of restriction are poorly defined. Here, we demonstrate that the cellular E3 ligase LXR-inducible degrader of low-density lipoprotein receptor (IDOL) targets the human cytomegalovirus (HMCV) UL136p33 protein for turnover. encodes multiple proteins that differentially impact latency and reactivation. UL136p33 is a determinant of reactivation. UL136p33 is targeted for rapid turnover by the proteasome, and its stabilization by mutation of lysine residues to arginine results in a failure to quiet replication for latency. We show that IDOL targets UL136p33 for turnover but not the stabilized variant. IDOL is highly expressed in undifferentiated hematopoietic cells where HCMV establishes latency but is sharply downregulated upon differentiation, a stimulus for reactivation. We hypothesize that IDOL maintains low levels of UL136p33 for the establishment of latency. Consistent with this hypothesis, knockdown of IDOL impacts viral gene expression in wild-type (WT) HCMV infection but not in infection where UL136p33 has been stabilized. Furthermore, the induction of LXR signaling restricts WT HCMV reactivation from latency but does not affect the replication of a recombinant virus expressing a stabilized variant of UL136p33. This work establishes the UL136p33-IDOL interaction as a key regulator of the bistable switch between latency and reactivation. It further suggests a model whereby a key viral determinant of HCMV reactivation is regulated by a host E3 ligase and acts as a sensor at the tipping point between the decision to maintain the latent state or exit latency for reactivation. Herpesviruses establish lifelong latent infections, which pose an important risk for disease particularly in the immunocompromised. Our work is focused on the betaherpesvirus human cytomegalovirus (HCMV) that latently infects the majority of the population worldwide. Defining the mechanisms by which HCMV establishes latency or reactivates from latency is important for controlling viral disease. Here, we demonstrate that the cellular inducible degrader of low-density lipoprotein receptor (IDOL) targets a HCMV determinant of reactivation for degradation. The instability of this determinant is important for the establishment of latency. This work defines a pivotal virus-host interaction that allows HCMV to sense changes in host biology to navigate decisions to establish latency or to replicate.
肝 X 受体 (LXR) 信号广泛抑制病毒复制;然而,限制机制尚不清楚。在这里,我们证明细胞 E3 连接酶 LXR 诱导的低密度脂蛋白受体 (IDOL) 的降解物可靶向人类巨细胞病毒 (HMCV) UL136p33 蛋白进行降解。编码多种蛋白,这些蛋白差异影响潜伏和再激活。UL136p33 是再激活的决定因素。UL136p33 通过蛋白酶体进行快速降解,其赖氨酸残基突变为精氨酸会导致潜伏时复制不能安静。我们表明,IDOL 可靶向 UL136p33 进行降解,但不能靶向稳定的变体。IDOL 在未分化的造血细胞中高度表达,HCMV 在这些细胞中建立潜伏,但在分化时急剧下调,这是再激活的刺激因素。我们假设 IDOL 维持 UL136p33 的低水平以建立潜伏。与该假说一致,IDOL 的敲低会影响野生型 (WT) HCMV 感染中的病毒基因表达,但不会影响稳定 UL136p33 的变体的感染。此外,LXR 信号的诱导限制了 WT HCMV 从潜伏中再激活,但不影响表达 UL136p33 稳定变体的重组病毒的复制。这项工作确立了 UL136p33-IDOL 相互作用作为潜伏和再激活之间双稳态开关的关键调节剂。它进一步表明,一种模型表明,HCMV 再激活的一个关键病毒决定因素受宿主 E3 连接酶调控,并作为维持潜伏状态或退出潜伏以进行再激活的决策的临界点的传感器。疱疹病毒建立终身潜伏感染,这对疾病构成了重要风险,尤其是在免疫功能低下的人群中。我们的工作集中在β疱疹病毒人类巨细胞病毒 (HCMV) 上,该病毒在全球范围内的大多数人群中潜伏感染。定义 HCMV 建立潜伏或从潜伏中再激活的机制对于控制病毒疾病很重要。在这里,我们证明细胞诱导的低密度脂蛋白受体 (IDOL) 的降解物可靶向 HCMV 再激活决定因素进行降解。该决定因素的不稳定性对于建立潜伏很重要。这项工作定义了一个关键的病毒-宿主相互作用,使 HCMV 能够感知宿主生物学的变化,从而做出建立潜伏或复制的决策。